1. < Home

MASLD

VPS4A is the selective receptor for lipophagy in mice and humans

Das D, Sharma M, Gahlot D, Nia SS, Gain C, Mecklenburg M, Zhou ZH, Bourdenx M, Thukral L, Martinez-Lopez N, Singh R. VPS4A is the[...]

By sjmartinez • November 14, 2024
The Role of RNA Splicing in Liver Function and Disease: A Focus on Metabolic Dysfunction-Associated Steatotic Liver Disease

Kaminska D. The Role of RNA Splicing in Liver Function and Disease: A Focus on Metabolic Dysfunction-Associated Steatotic Liver Disease. Genes (Basel). 2024 Sep 8;15(9):1181.[...]

By sjmartinez • September 29, 2024
Single nucleus RNA-sequencing integrated into risk variant colocalization discovers 17 cell-type-specific abdominal obesity genes for metabolic dysfunction-associated steatotic liver disease

Lee SHT, Garske KM, Arasu UT, Kar A, Miao Z, Alvarez M, Koka A, Darci-Maher N, Benhammou JN, Pan DZ, Örd T, Kaminska D, Männistö[...]

By sjmartinez • July 12, 2024
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: systematic analysis from the global burden of disease study 2019

Danpanichkul P, Suparan K, Dutta P, Kaeosri C, Sukphutanan B, Pang Y, Kulthamrongsri N, Jaisa-Aad M, Ng CH, Teng M, Nakano M, Morishita A, Alkhouri[...]

By sjmartinez • June 29, 2024
Resolution of metabolic dysfunction-associated steatohepatitis with estradiol in a transgender female: A case report

Steiger A, VanderVeen NT, Kang EH, Weimer AK. Resolution of metabolic dysfunction-associated steatohepatitis with estradiol in a transgender female: A case report. JPGN Rep. 2024 Feb[...]

By sjmartinez • May 17, 2024